Request for Covid-19 Impact Assessment of this Report
The United States Molecular Imaging Agents market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Molecular Imaging Agents market, reaching US$ million by the year 2028. As for the Europe Molecular Imaging Agents landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Molecular Imaging Agents players cover General Electric, Bracco Diagnostic, Eisai, and Guerbet, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Imaging Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Small Molecules
Peptides
Engineered Protein Fragments
Aptamers
Nanoparticles
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Oncology
Cardiology
Gastrointestinal Disorders
Neurology Disorders
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
General Electric
Bracco Diagnostic
Eisai
Guerbet
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Molecular Imaging Agents Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Molecular Imaging Agents by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Molecular Imaging Agents by Country/Region, 2017, 2022 & 2028
2.2 Molecular Imaging Agents Segment by Type
2.2.1 Small Molecules
2.2.2 Peptides
2.2.3 Engineered Protein Fragments
2.2.4 Aptamers
2.2.5 Nanoparticles
2.2.6 Others
2.3 Molecular Imaging Agents Sales by Type
2.3.1 Global Molecular Imaging Agents Sales Market Share by Type (2017-2022)
2.3.2 Global Molecular Imaging Agents Revenue and Market Share by Type (2017-2022)
2.3.3 Global Molecular Imaging Agents Sale Price by Type (2017-2022)
2.4 Molecular Imaging Agents Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Gastrointestinal Disorders
2.4.4 Neurology Disorders
2.4.5 Others
2.5 Molecular Imaging Agents Sales by Application
2.5.1 Global Molecular Imaging Agents Sale Market Share by Application (2017-2022)
2.5.2 Global Molecular Imaging Agents Revenue and Market Share by Application (2017-2022)
2.5.3 Global Molecular Imaging Agents Sale Price by Application (2017-2022)
3 Global Molecular Imaging Agents by Company
3.1 Global Molecular Imaging Agents Breakdown Data by Company
3.1.1 Global Molecular Imaging Agents Annual Sales by Company (2020-2022)
3.1.2 Global Molecular Imaging Agents Sales Market Share by Company (2020-2022)
3.2 Global Molecular Imaging Agents Annual Revenue by Company (2020-2022)
3.2.1 Global Molecular Imaging Agents Revenue by Company (2020-2022)
3.2.2 Global Molecular Imaging Agents Revenue Market Share by Company (2020-2022)
3.3 Global Molecular Imaging Agents Sale Price by Company
3.4 Key Manufacturers Molecular Imaging Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Molecular Imaging Agents Product Location Distribution
3.4.2 Players Molecular Imaging Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Molecular Imaging Agents by Geographic Region
4.1 World Historic Molecular Imaging Agents Market Size by Geographic Region (2017-2022)
4.1.1 Global Molecular Imaging Agents Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Molecular Imaging Agents Annual Revenue by Geographic Region
4.2 World Historic Molecular Imaging Agents Market Size by Country/Region (2017-2022)
4.2.1 Global Molecular Imaging Agents Annual Sales by Country/Region (2017-2022)
4.2.2 Global Molecular Imaging Agents Annual Revenue by Country/Region
4.3 Americas Molecular Imaging Agents Sales Growth
4.4 APAC Molecular Imaging Agents Sales Growth
4.5 Europe Molecular Imaging Agents Sales Growth
4.6 Middle East & Africa Molecular Imaging Agents Sales Growth
5 Americas
5.1 Americas Molecular Imaging Agents Sales by Country
5.1.1 Americas Molecular Imaging Agents Sales by Country (2017-2022)
5.1.2 Americas Molecular Imaging Agents Revenue by Country (2017-2022)
5.2 Americas Molecular Imaging Agents Sales by Type
5.3 Americas Molecular Imaging Agents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Molecular Imaging Agents Sales by Region
6.1.1 APAC Molecular Imaging Agents Sales by Region (2017-2022)
6.1.2 APAC Molecular Imaging Agents Revenue by Region (2017-2022)
6.2 APAC Molecular Imaging Agents Sales by Type
6.3 APAC Molecular Imaging Agents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Molecular Imaging Agents by Country
7.1.1 Europe Molecular Imaging Agents Sales by Country (2017-2022)
7.1.2 Europe Molecular Imaging Agents Revenue by Country (2017-2022)
7.2 Europe Molecular Imaging Agents Sales by Type
7.3 Europe Molecular Imaging Agents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Molecular Imaging Agents by Country
8.1.1 Middle East & Africa Molecular Imaging Agents Sales by Country (2017-2022)
8.1.2 Middle East & Africa Molecular Imaging Agents Revenue by Country (2017-2022)
8.2 Middle East & Africa Molecular Imaging Agents Sales by Type
8.3 Middle East & Africa Molecular Imaging Agents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Molecular Imaging Agents
10.3 Manufacturing Process Analysis of Molecular Imaging Agents
10.4 Industry Chain Structure of Molecular Imaging Agents
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Molecular Imaging Agents Distributors
11.3 Molecular Imaging Agents Customer
12 World Forecast Review for Molecular Imaging Agents by Geographic Region
12.1 Global Molecular Imaging Agents Market Size Forecast by Region
12.1.1 Global Molecular Imaging Agents Forecast by Region (2023-2028)
12.1.2 Global Molecular Imaging Agents Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Molecular Imaging Agents Forecast by Type
12.7 Global Molecular Imaging Agents Forecast by Application
13 Key Players Analysis
13.1 General Electric
13.1.1 General Electric Company Information
13.1.2 General Electric Molecular Imaging Agents Product Offered
13.1.3 General Electric Molecular Imaging Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 General Electric Main Business Overview
13.1.5 General Electric Latest Developments
13.2 Bracco Diagnostic
13.2.1 Bracco Diagnostic Company Information
13.2.2 Bracco Diagnostic Molecular Imaging Agents Product Offered
13.2.3 Bracco Diagnostic Molecular Imaging Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bracco Diagnostic Main Business Overview
13.2.5 Bracco Diagnostic Latest Developments
13.3 Eisai
13.3.1 Eisai Company Information
13.3.2 Eisai Molecular Imaging Agents Product Offered
13.3.3 Eisai Molecular Imaging Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eisai Main Business Overview
13.3.5 Eisai Latest Developments
13.4 Guerbet
13.4.1 Guerbet Company Information
13.4.2 Guerbet Molecular Imaging Agents Product Offered
13.4.3 Guerbet Molecular Imaging Agents Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Guerbet Main Business Overview
13.4.5 Guerbet Latest Developments
14 Research Findings and Conclusion
Table 1. Molecular Imaging Agents Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Molecular Imaging Agents Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Small Molecules
Table 4. Major Players of Peptides
Table 5. Major Players of Engineered Protein Fragments
Table 6. Major Players of Aptamers
Table 7. Major Players of Nanoparticles
Table 8. Major Players of Others
Table 9. Global Molecular Imaging Agents Sales by Type (2017-2022) & (K MT)
Table 10. Global Molecular Imaging Agents Sales Market Share by Type (2017-2022)
Table 11. Global Molecular Imaging Agents Revenue by Type (2017-2022) & ($ million)
Table 12. Global Molecular Imaging Agents Revenue Market Share by Type (2017-2022)
Table 13. Global Molecular Imaging Agents Sale Price by Type (2017-2022) & (USD/MT)
Table 14. Global Molecular Imaging Agents Sales by Application (2017-2022) & (K MT)
Table 15. Global Molecular Imaging Agents Sales Market Share by Application (2017-2022)
Table 16. Global Molecular Imaging Agents Revenue by Application (2017-2022)
Table 17. Global Molecular Imaging Agents Revenue Market Share by Application (2017-2022)
Table 18. Global Molecular Imaging Agents Sale Price by Application (2017-2022) & (USD/MT)
Table 19. Global Molecular Imaging Agents Sales by Company (2020-2022) & (K MT)
Table 20. Global Molecular Imaging Agents Sales Market Share by Company (2020-2022)
Table 21. Global Molecular Imaging Agents Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Molecular Imaging Agents Revenue Market Share by Company (2020-2022)
Table 23. Global Molecular Imaging Agents Sale Price by Company (2020-2022) & (USD/MT)
Table 24. Key Manufacturers Molecular Imaging Agents Producing Area Distribution and Sales Area
Table 25. Players Molecular Imaging Agents Products Offered
Table 26. Molecular Imaging Agents Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Molecular Imaging Agents Sales by Geographic Region (2017-2022) & (K MT)
Table 30. Global Molecular Imaging Agents Sales Market Share Geographic Region (2017-2022)
Table 31. Global Molecular Imaging Agents Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Molecular Imaging Agents Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Molecular Imaging Agents Sales by Country/Region (2017-2022) & (K MT)
Table 34. Global Molecular Imaging Agents Sales Market Share by Country/Region (2017-2022)
Table 35. Global Molecular Imaging Agents Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Molecular Imaging Agents Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Molecular Imaging Agents Sales by Country (2017-2022) & (K MT)
Table 38. Americas Molecular Imaging Agents Sales Market Share by Country (2017-2022)
Table 39. Americas Molecular Imaging Agents Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Molecular Imaging Agents Revenue Market Share by Country (2017-2022)
Table 41. Americas Molecular Imaging Agents Sales by Type (2017-2022) & (K MT)
Table 42. Americas Molecular Imaging Agents Sales Market Share by Type (2017-2022)
Table 43. Americas Molecular Imaging Agents Sales by Application (2017-2022) & (K MT)
Table 44. Americas Molecular Imaging Agents Sales Market Share by Application (2017-2022)
Table 45. APAC Molecular Imaging Agents Sales by Region (2017-2022) & (K MT)
Table 46. APAC Molecular Imaging Agents Sales Market Share by Region (2017-2022)
Table 47. APAC Molecular Imaging Agents Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Molecular Imaging Agents Revenue Market Share by Region (2017-2022)
Table 49. APAC Molecular Imaging Agents Sales by Type (2017-2022) & (K MT)
Table 50. APAC Molecular Imaging Agents Sales Market Share by Type (2017-2022)
Table 51. APAC Molecular Imaging Agents Sales by Application (2017-2022) & (K MT)
Table 52. APAC Molecular Imaging Agents Sales Market Share by Application (2017-2022)
Table 53. Europe Molecular Imaging Agents Sales by Country (2017-2022) & (K MT)
Table 54. Europe Molecular Imaging Agents Sales Market Share by Country (2017-2022)
Table 55. Europe Molecular Imaging Agents Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Molecular Imaging Agents Revenue Market Share by Country (2017-2022)
Table 57. Europe Molecular Imaging Agents Sales by Type (2017-2022) & (K MT)
Table 58. Europe Molecular Imaging Agents Sales Market Share by Type (2017-2022)
Table 59. Europe Molecular Imaging Agents Sales by Application (2017-2022) & (K MT)
Table 60. Europe Molecular Imaging Agents Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Molecular Imaging Agents Sales by Country (2017-2022) & (K MT)
Table 62. Middle East & Africa Molecular Imaging Agents Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Molecular Imaging Agents Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Molecular Imaging Agents Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Molecular Imaging Agents Sales by Type (2017-2022) & (K MT)
Table 66. Middle East & Africa Molecular Imaging Agents Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Molecular Imaging Agents Sales by Application (2017-2022) & (K MT)
Table 68. Middle East & Africa Molecular Imaging Agents Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Molecular Imaging Agents
Table 70. Key Market Challenges & Risks of Molecular Imaging Agents
Table 71. Key Industry Trends of Molecular Imaging Agents
Table 72. Molecular Imaging Agents Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Molecular Imaging Agents Distributors List
Table 75. Molecular Imaging Agents Customer List
Table 76. Global Molecular Imaging Agents Sales Forecast by Region (2023-2028) & (K MT)
Table 77. Global Molecular Imaging Agents Sales Market Forecast by Region
Table 78. Global Molecular Imaging Agents Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Molecular Imaging Agents Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Molecular Imaging Agents Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Americas Molecular Imaging Agents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Molecular Imaging Agents Sales Forecast by Region (2023-2028) & (K MT)
Table 83. APAC Molecular Imaging Agents Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Molecular Imaging Agents Sales Forecast by Country (2023-2028) & (K MT)
Table 85. Europe Molecular Imaging Agents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Molecular Imaging Agents Sales Forecast by Country (2023-2028) & (K MT)
Table 87. Middle East & Africa Molecular Imaging Agents Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Molecular Imaging Agents Sales Forecast by Type (2023-2028) & (K MT)
Table 89. Global Molecular Imaging Agents Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Molecular Imaging Agents Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Molecular Imaging Agents Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Molecular Imaging Agents Sales Forecast by Application (2023-2028) & (K MT)
Table 93. Global Molecular Imaging Agents Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Molecular Imaging Agents Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Molecular Imaging Agents Revenue Market Share Forecast by Application (2023-2028)
Table 96. General Electric Basic Information, Molecular Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 97. General Electric Molecular Imaging Agents Product Offered
Table 98. General Electric Molecular Imaging Agents Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 99. General Electric Main Business
Table 100. General Electric Latest Developments
Table 101. Bracco Diagnostic Basic Information, Molecular Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 102. Bracco Diagnostic Molecular Imaging Agents Product Offered
Table 103. Bracco Diagnostic Molecular Imaging Agents Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 104. Bracco Diagnostic Main Business
Table 105. Bracco Diagnostic Latest Developments
Table 106. Eisai Basic Information, Molecular Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 107. Eisai Molecular Imaging Agents Product Offered
Table 108. Eisai Molecular Imaging Agents Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 109. Eisai Main Business
Table 110. Eisai Latest Developments
Table 111. Guerbet Basic Information, Molecular Imaging Agents Manufacturing Base, Sales Area and Its Competitors
Table 112. Guerbet Molecular Imaging Agents Product Offered
Table 113. Guerbet Molecular Imaging Agents Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 114. Guerbet Main Business
Table 115. Guerbet Latest Developments
List of Figures
Figure 1. Picture of Molecular Imaging Agents
Figure 2. Molecular Imaging Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Molecular Imaging Agents Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Molecular Imaging Agents Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Molecular Imaging Agents Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Small Molecules
Figure 10. Product Picture of Peptides
Figure 11. Product Picture of Engineered Protein Fragments
Figure 12. Product Picture of Aptamers
Figure 13. Product Picture of Nanoparticles
Figure 14. Product Picture of Others
Figure 15. Global Molecular Imaging Agents Sales Market Share by Type in 2021
Figure 16. Global Molecular Imaging Agents Revenue Market Share by Type (2017-2022)
Figure 17. Molecular Imaging Agents Consumed in Oncology
Figure 18. Global Molecular Imaging Agents Market: Oncology (2017-2022) & (K MT)
Figure 19. Molecular Imaging Agents Consumed in Cardiology
Figure 20. Global Molecular Imaging Agents Market: Cardiology (2017-2022) & (K MT)
Figure 21. Molecular Imaging Agents Consumed in Gastrointestinal Disorders
Figure 22. Global Molecular Imaging Agents Market: Gastrointestinal Disorders (2017-2022) & (K MT)
Figure 23. Molecular Imaging Agents Consumed in Neurology Disorders
Figure 24. Global Molecular Imaging Agents Market: Neurology Disorders (2017-2022) & (K MT)
Figure 25. Molecular Imaging Agents Consumed in Others
Figure 26. Global Molecular Imaging Agents Market: Others (2017-2022) & (K MT)
Figure 27. Global Molecular Imaging Agents Sales Market Share by Application (2017-2022)
Figure 28. Global Molecular Imaging Agents Revenue Market Share by Application in 2021
Figure 29. Molecular Imaging Agents Revenue Market by Company in 2021 ($ Million)
Figure 30. Global Molecular Imaging Agents Revenue Market Share by Company in 2021
Figure 31. Global Molecular Imaging Agents Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global Molecular Imaging Agents Revenue Market Share by Geographic Region in 2021
Figure 33. Global Molecular Imaging Agents Sales Market Share by Region (2017-2022)
Figure 34. Global Molecular Imaging Agents Revenue Market Share by Country/Region in 2021
Figure 35. Americas Molecular Imaging Agents Sales 2017-2022 (K MT)
Figure 36. Americas Molecular Imaging Agents Revenue 2017-2022 ($ Millions)
Figure 37. APAC Molecular Imaging Agents Sales 2017-2022 (K MT)
Figure 38. APAC Molecular Imaging Agents Revenue 2017-2022 ($ Millions)
Figure 39. Europe Molecular Imaging Agents Sales 2017-2022 (K MT)
Figure 40. Europe Molecular Imaging Agents Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Molecular Imaging Agents Sales 2017-2022 (K MT)
Figure 42. Middle East & Africa Molecular Imaging Agents Revenue 2017-2022 ($ Millions)
Figure 43. Americas Molecular Imaging Agents Sales Market Share by Country in 2021
Figure 44. Americas Molecular Imaging Agents Revenue Market Share by Country in 2021
Figure 45. United States Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC Molecular Imaging Agents Sales Market Share by Region in 2021
Figure 50. APAC Molecular Imaging Agents Revenue Market Share by Regions in 2021
Figure 51. China Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 55. India Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe Molecular Imaging Agents Sales Market Share by Country in 2021
Figure 58. Europe Molecular Imaging Agents Revenue Market Share by Country in 2021
Figure 59. Germany Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 60. France Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa Molecular Imaging Agents Sales Market Share by Country in 2021
Figure 65. Middle East & Africa Molecular Imaging Agents Revenue Market Share by Country in 2021
Figure 66. Egypt Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country Molecular Imaging Agents Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Molecular Imaging Agents in 2021
Figure 72. Manufacturing Process Analysis of Molecular Imaging Agents
Figure 73. Industry Chain Structure of Molecular Imaging Agents
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...